Log in

AMBS Amarantus Bioscience Holdings, Inc. OTC · United States

Amarantus Bioscience Holdings (AMBS) news

Amarantus Bioscience Holdings, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker AMBS, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Amarantus Bioscience Holdings news

We have not published a story on Amarantus Bioscience Holdings yet. When there is news, it will appear here.

Questions about Amarantus Bioscience Holdings

What is the ticker symbol of Amarantus Bioscience Holdings?

Amarantus Bioscience Holdings, Inc. trades under the ticker AMBS on OTC.

Where is Amarantus Bioscience Holdings listed?

Amarantus Bioscience Holdings, Inc. is listed on OTC.

Which country or territory is Amarantus Bioscience Holdings listed under?

Our directory records Amarantus Bioscience Holdings, Inc. under United States.

What does Amarantus Bioscience Holdings do?

Our directory classifies Amarantus Bioscience Holdings, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Amarantus Bioscience Holdings?

The ISIN recorded for Amarantus Bioscience Holdings, Inc. is US02300U2050.

Does aibio.space cover Amarantus Bioscience Holdings?

aibio.space lists Amarantus Bioscience Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Amarantus Bioscience Holdings?

Companies in our directory listed in the same country and business area as Amarantus Bioscience Holdings: Upstream Bio, Decoy Therapeutics, Armata Pharmaceuticals, ThermoGenesis Holdings, Pliant Therapeutics, PureTech Health.

Investor discussion: Amarantus Bioscience Holdings

Members talk about Amarantus Bioscience Holdings (AMBS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:AMBS on TradingView.

Listing details

Amarantus Bioscience Holdings, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker AMBS, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Amarantus Bioscience Holdings, Inc.
Ticker
AMBS
Listing
OTC
Country or territory
United States
Business scope
Biotechnology
ISIN
US02300U2050
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.